MedTech Startup Axio Biosolutions Raises $6 Million in Series B2 Funding
Axio Biosolutions, a MedTech company, announced a $6 million Series B2 equity raise led by TrueScale Capital, with participation from existing investors Omidyar Network India, University of California–Ratan Tata Fund,...
Read more